Anika Therapeutics reported $18.18M in Selling and Administration Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 7M
Acceleron Pharma XLRN:US $ 31.06M 4.85M
Acorda Therapeutics ACOR:US $ 32.27M 608K
Adamas Pharmaceuticals ADMS:US 26.64M 6.35M
Agenus AGEN:US $ 16.35M 3.68M
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Anika Therapeutics ANIK:US $ 18.18M 3M
Arrowhead Research ARWR:US $ 16.19M 7.54M
Chemocentryx CCXI:US $ 16.26M 3.55M
Clovis Oncology CLVS:US $ 29.94M 10.82M
Dicerna Pharmaceuticals DRNA:US $ 20.67M 2.09M
Enanta Pharmaceuticals ENTA:US $ 8.33M 949K
Flexion Therapeutics FLXN:US $ 27.6M 3.94M
Halozyme Therapeutics HALO:US $ 11.06M 632K
Heron Therapeutics HRTX:US $ 24.81M 3.25M
Immunogen IMGN:US $ 9.73M 481K
Insmed INSM:US $ 51.55M 4.47M
Integra Lifesciences IART:US $ 155.99M 10.85M
Intrexon XON:US $ 18.7M 8.94M
Johnson & Johnson JNJ:US $ 6.07B 641M
Karyopharm Therapeutics KPTI:US $ 37.65M 3.72M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Macrogenics MGNX:US $ 15.23M 198K
Merit Medical Systems MMSI:US $ 91.56M 10.54M
Peregrine Pharmaceuticals PPHM:US $ 5.06M 1.04M
Rigel Pharmaceuticals RIGL:US $ 22.12M 303K
Sangamo Biosciences SGMO:US $ 16.15M 726K
Stryker SYK:US $ 1.44B 46M
Surmodics SRDX:US $ 7.91M 884K
Veracyte VCYT:US $ 28.61M 9.34M
Xencor XNCR:US $ 8.23M 623K
Zimmer Biomet Holdings Inc ZBH:US $ 770.1M 123.8M